Why did Amazon’s stock surge after Q3 earnings?
What impact will Trump's refugee cap cuts have?
How is AI spending reshaping Big Tech profits?
Why did Disney pull channels from YouTube TV?
What caused Nvidia's market valuation to hit $5 trillion?
How will Trump's call to end the filibuster affect shutdown?
Why are penny phases out impacting retailers and banks?
Neurocrine Shares Rise, But Pull Back From Steep Gains, On Strong Ingrezza Quarter
investors.com/news/technology/neurocrine-biosciences-earnings-neurocrine-stock-q3-2025
Shares of Neurocrine Biosciences rose late Tuesday on better-than-expected third-quarter sales and earnings.
The post Neurocrine Shares Rise, But Pull Back From Steep Gains, On Strong Ingrezza Quarter appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-10-28 20:13:57.